Filgrastim Unknown Status Phase 2 Trials for Malignant Lymphomas / Multiple Myeloma and Plasma Cell Neoplasm Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003163Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers